Furthermore, the average of the expression of TDO2, AhR, and ZEB1 genes is higher in basal-like breast cancer (TNBC) than that in luminal A/B [estrogen receptor–positive (ER+)] breast cancer and when generally comparing ER− versus ER+ tumors (Fig. 8I). This evidence concerns the gene ESR1 and breast cancer.